The Effects of Vitamin D Supplementation on Respiratory Infections in Children under 6 Years Old: A Systematic Review
Abstract
:1. Introduction
2. Materials and Methods
2.1. Review Protocol
2.2. Selection Process
2.3. Data Extraction and Quality Assessment
3. Results
3.1. Analysis of the Included Studies
3.2. Patients’ Characteristics and Interventions
3.3. Vitamin D Levels and Prevalence of Infections
3.4. Study Outcomes and Vitamin D Effect Measurement
4. Discussion
4.1. Summary and Contributions
4.2. Strengths and Limitations
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Bhurtel, R.; Pokhrel, R.P.; Kalakheti, B. Acute Respiratory Infections among Under-five Children Admitted in a Tertiary Hospital of Nepal: A Descriptive Cross-sectional Study. J. Nepal Med. Assoc. 2022, 60, 17–21. [Google Scholar] [CrossRef] [PubMed]
- Boeriu, E.; Borda, A.; Vulcanescu, D.D.; Sarbu, V.; Arghirescu, S.T.; Ciorica, O.; Bratosin, F.; Marincu, I.; Horhat, F.G. Diagnosis and Management of Febrile Neutropenia in Pediatric Oncology Patients—A Systematic Review. Diagnostics 2022, 12, 1800. [Google Scholar] [CrossRef] [PubMed]
- Hasan, M.M.; Saha, K.K.; Yunus, R.M.; Alam, K. Prevalence of acute respiratory infections among children in India: Regional inequalities and risk factors. Matern Child Health J. 2022, 26, 1594–1602. [Google Scholar] [CrossRef]
- Piedimonte, G.; Perez, M.K. Respiratory syncytial virus infection and bronchiolitis. Pediatr. Rev. 2014, 35, 519–530, Erratum in Pediatr. Rev. 2015, 36, 85. [Google Scholar] [CrossRef] [PubMed]
- Hon, K.L.; Leung, A.K. Severe childhood respiratory viral infections. Adv. Pediatr. 2009, 56, 47–73. [Google Scholar] [CrossRef]
- Lai, X.; Rong, H.; Ma, X.; Hou, Z.; Li, S.; Jing, R.; Zhang, H.; Lyu, Y.; Wang, J.; Feng, H.; et al. The Economic Burden of Influenza-Like Illness among Children, Chronic Disease Patients, and the Elderly in China: A National Cross-Sectional Survey. Int. J. Environ. Res. Public Health 2021, 18, 6277. [Google Scholar] [CrossRef]
- Antonova, E.N.; Rycroft, C.E.; Ambrose, C.S.; Heikkinen, T.; Principi, N. Burden of paediatric influenza in Western Europe: A systematic review. BMC Public Health 2012, 12, 968. [Google Scholar] [CrossRef] [Green Version]
- Bui, L.; Zhu, Z.; Hawkins, S.; Cortez-Resendiz, A.; Bellon, A. Vitamin D regulation of the immune system and its implications for COVID-19: A mini review. SAGE Open Med. 2021, 9, 20503121211014073. [Google Scholar] [CrossRef]
- Engelsen, O. The relationship between ultraviolet radiation exposure and vitamin D status. Nutrients 2010, 2, 482–495. [Google Scholar] [CrossRef] [Green Version]
- Dahma, G.; Neamtu, R.; Nitu, R.; Gluhovschi, A.; Bratosin, F.; Grigoras, M.L.; Silaghi, C.; Citu, C.; Orlu, I.N.; Bhattarai, S.; et al. The Influence of Maternal Vitamin D Supplementation in Pregnancies Associated with Preeclampsia: A Case-Control Study. Nutrients 2022, 14, 3008. [Google Scholar] [CrossRef]
- Álvarez-Mercado, A.I.; Mesa, M.D.; Gil, Á. Vitamin D: Role in chronic and acute diseases. Encycl. Hum. Nutr. 2023, 535–544. [Google Scholar] [CrossRef]
- Dahma, G.; Craina, M.; Dumitru, C.; Neamtu, R.; Popa, Z.L.; Gluhovschi, A.; Citu, C.; Bratosin, F.; Bloanca, V.; Alambaram, S.; et al. A Prospective Analysis of Vitamin D Levels in Pregnant Women Diagnosed with Gestational Hypertension after SARS-CoV-2 Infection. J. Pers. Med. 2023, 13, 317. [Google Scholar] [CrossRef] [PubMed]
- Taha, R.; Abureesh, S.; Alghamdi, S.; Hassan, R.Y.; Cheikh, M.M.; Bagabir, R.A.; Almoallim, H.; Abdulkhaliq, A. The Relationship between Vitamin D and Infections Including COVID-19: Any Hopes? Int. J. Gen. Med. 2021, 14, 3849–3870. [Google Scholar] [CrossRef] [PubMed]
- Shoemaker, M.E.; Huynh, L.M.; Smith, C.M.; Mustad, V.A.; Duarte, M.O.; Cramer, J.T. Immunomodulatory Effects of Vitamin D and Prevention of Respiratory Tract Infections and COVID-19. Top. Clin. Nutr. 2022, 37, 203–217. [Google Scholar] [CrossRef] [PubMed]
- Pilut, C.N.; Citu, C.; Gorun, F.; Bratosin, F.; Gorun, O.M.; Burlea, B.; Citu, I.M.; Grigoras, M.L.; Manolescu, D.; Gluhovschi, A. The Utility of Laboratory Parameters for Cardiac Inflammation in Heart Failure Patients Hospitalized with SARS-CoV-2 Infection. Diagnostics 2022, 12, 824. [Google Scholar] [CrossRef]
- Athanassiou, L.; Mavragani, C.P.; Koutsilieris, M. The Immunomodulatory Properties of Vitamin D. Mediterr. J. Rheumatol. 2022, 33, 7–13. [Google Scholar] [CrossRef]
- Papava, I.; Dehelean, L.; Romosan, R.S.; Bondrescu, M.; Dimeny, C.Z.; Domuta, E.M.; Bratosin, F.; Bogdan, I.; Grigoras, M.L.; Tigmeanu, C.V.; et al. The Impact of Hyper-Acute Inflammatory Response on Stress Adaptation and Psychological Symptoms of COVID-19 Patients. Int. J. Environ. Res. Public Health 2022, 19, 6501. [Google Scholar] [CrossRef]
- Gagnon, C.; Lu, Z.X.; Magliano, D.J.; Dunstan, D.W.; Shaw, J.E.; Zimmet, P.Z.; Sikaris, K.; Ebeling, P.R.; Daly, R.M. Low serum 25-hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at five years: Results from a national, population-based prospective study (The Australian Diabetes, Obesity and Lifestyle Study: AusDiab). J. Clin. Endocrinol. Metab. 2012, 97, 1953–1961. [Google Scholar] [CrossRef] [Green Version]
- Gibson-Moore, H. Vitamin D: What’s new a year on from the COVID-19 outbreak? Nutr. Bull. 2021, 46, 195–205. [Google Scholar] [CrossRef]
- Mocanu, A.; Lazureanu, V.E.; Laza, R.; Marinescu, A.R.; Cut, T.G.; Sincaru, S.-V.; Marza, A.M.; Popescu, I.-M.; Herlo, L.-F.; Nelson-Twakor, A.; et al. Laboratory Findings and Clinical Outcomes of ICU-admitted COVID-19 Patients: A Retrospective Assessment of Particularities Identified among Romanian Minorities. J. Pers. Med. 2023, 13, 195. [Google Scholar] [CrossRef]
- Turaiche, M.; Grigoras, M.L.; Bratosin, F.; Bogdan, I.; Bota, A.V.; Cerbu, B.; Gurban, C.V.; Wulandari, P.H.; Gurumurthy, S.; Hemaswini, K.; et al. Disease Progression, Clinical Features, and Risk Factors for Pneumonia in Unvaccinated Children and Adolescents with Measles: A Re-Emerging Disease in Romania. Int. J. Environ. Res. Public Health 2022, 19, 13165. [Google Scholar] [CrossRef] [PubMed]
- Jat, K.R. Vitamin D deficiency and lower respiratory tract infections in children: A systematic review and meta-analysis of observational studies. Trop. Dr. 2017, 47, 77–84. [Google Scholar] [CrossRef] [PubMed]
- Raju, A.; Luthra, G.; Shahbaz, M.; Almatooq, H.; Foucambert, P.; Esbrand, F.D.; Zafar, S.; Panthangi, V.; Kurupp, A.R.C.; Khan, S. Role of Vitamin D Deficiency in Increased Susceptibility to Respiratory Infections Among Children: A Systematic Review. Cureus 2022, 14, e29205. [Google Scholar] [CrossRef]
- Citu, I.M.; Citu, C.; Margan, M.-M.; Craina, M.; Neamtu, R.; Gorun, O.M.; Burlea, B.; Bratosin, F.; Rosca, O.; Grigoras, M.L.; et al. Calcium, Magnesium, and Zinc Supplementation during Pregnancy: The Additive Value of Micronutrients on Maternal Immune Response after SARS-CoV-2 Infection. Nutrients 2022, 14, 1445. [Google Scholar] [CrossRef]
- Kloc, M.; Ghobrial, R.M.; Kuchar, E.; Lewicki, S.; Kubiak, J.Z. Development of child immunity in the context of COVID-19 pandemic. Clin. Immunol. 2020, 217, 108510. [Google Scholar] [CrossRef]
- Dhammi, I.K.; Kumar, S. Medical subject headings (MeSH) terms. Indian. J. Orthop. 2014, 48, 443–444. [Google Scholar]
- Moher, D. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 2009, 6, e1000097. [Google Scholar] [CrossRef] [Green Version]
- Schiavo, J.H. PROSPERO: An International Register of Systematic Review Protocols. Med. Ref. Serv. Q. 2019, 38, 171–180. [Google Scholar] [CrossRef]
- Foster, E.D.; Deardorff, A. Open Science Framework (OSF). J. Med. Libr. Assoc. 2017, 105, 203. [Google Scholar] [CrossRef] [Green Version]
- Cantrell, A.; Croot, E.; Johnson, M.; Wong, R.; Chambers, D.; Baxter, S.K.; Booth, A. Access to Primary and Community Health-Care Services for People 16 Years and over with Intellectual Disabilities: A Mapping and Targeted Systematic Review; (Health Services and Delivery Research, No. 8.5.) Appendix 11, Quality Appraisal of Included Studies; NIHR Journals Library: Southampton, UK, January 2020. Available online: https://www.ncbi.nlm.nih.gov/books/NBK553267/ (accessed on 7 May 2023).
- Leis, K.S.; McNally, J.D.; Montgomery, M.R.; Sankaran, K.; Karunanayake, C.; Rosenberg, A.M. Vitamin D intake in young children with acute lower respiratory infection. Transl. Pediatr. 2012, 1, 6–14. [Google Scholar] [CrossRef]
- Jensen, M.E.; Mailhot, G.; Alos, N.; Rousseau, E.; White, J.H.; Khamessan, A.; Ducharme, F.M. Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): A pilot randomised controlled trial. Trials 2016, 17, 353. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Aglipay, M.; Birken, C.S.; Parkin, P.C.; Loeb, M.B.; Thorpe, K.; Chen, Y.; Laupacis, A.; Mamdani, M.; Macarthur, C.; Hoch, J.S.; et al. Effect of High-Dose vs Standard-Dose Wintertime Vitamin D Supplementation on Viral Upper Respiratory Tract Infections in Young Healthy Children. JAMA 2017, 318, 245–254. [Google Scholar] [CrossRef] [PubMed]
- Hueniken, K.; Aglipay, M.; Birken, C.S.; Parkin, P.C.; Loeb, M.B.; Thorpe, K.E.; Dai, D.W.H.; Laupacis, A.; Mamdani, M.; Mazzulli, T. Effect of High-Dose Vitamin D Supplementation on Upper Respiratory Tract Infection Symptom Severity in Healthy Children. Pediatr. Infect. Dis. J. 2019, 38, 564–568. [Google Scholar] [CrossRef] [PubMed]
- Singh, N.; Kamble, D.; Mahantshetti, N.S. Effect of Vitamin D Supplementation in the Prevention of Recurrent Pneumonia in Under-Five Children. Indian J. Pediatr 2019, 86, 1105–1111. [Google Scholar] [CrossRef]
- Ducharme, F.M.; Jensen, M.; Mailhot, G.; Alos, N.; White, J.; Rousseau, E.; Tse, S.M.; Khamessan, A.; Vinet, B. Impact of two oral doses of 100,000 IU of vitamin D3 in preschoolers with viral-induced asthma: A pilot randomised controlled trial. Trials 2019, 20, 138. [Google Scholar] [CrossRef] [Green Version]
- Jadhav, S.; Khanwelkar, C.; Jadhav, A.; Seshla, S. Vitamin D supplementation in the prevention of recurrent acute respiratory tract infections in children aged <5 years. J. Med. Sci. 2021, 41, 129–133. [Google Scholar]
- Xiao, J.; He, W. The immunomodulatory effects of vitamin D drops in children with recurrent respiratory tract infections. Am. J. Transl. Res. 2021, 13, 1750–1756. [Google Scholar]
- Petrović, D.; Runjić, E.; Buljan, I.; Jeličić Kadić, A.; Markić, J. Knowledge and Practice of Pediatricians Regarding Hypovitaminosis D-A Survey across 33 European Countries. Children 2022, 9, 1831. [Google Scholar] [CrossRef]
- Lips, P.; de Jongh, R.T.; van Schoor, N.M. Trends in Vitamin D Status Around the World. JBMR Plus 2021, 5, e10585. [Google Scholar] [CrossRef]
- Won, J.W.; Jung, S.K.; Jung, I.A.; Lee, Y. Seasonal Changes in Vitamin D Levels of Healthy Children in Mid-Latitude, Asian Urban Area. Pediatr. Gastroenterol. Hepatol. Nutr. 2021, 24, 207–217. [Google Scholar] [CrossRef]
- Chailurkit, L.O.; Aekplakorn, W.; Ongphiphadhanakul, B. Regional variation and determinants of vitamin D status in sunshine-abundant Thailand. BMC Public Health 2011, 11, 853. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Martineau, A.R.; Jolliffe, D.A.; Hooper, R.L.; Greenberg, L.; Aloia, J.F.; Bergman, P.; Dubnov-Raz, G.; Esposito, S.; Ganmaa, D.; Camargo, C.A. Vitamin D supplementation to prevent acute respiratory tract infections: Systematic review and meta-analysis of individual participant data. BMJ 2017, 356, i6583. [Google Scholar] [CrossRef] [Green Version]
- Yakoob, M.Y.; Salam, R.A.; Khan, F.R.; Bhutta, Z.A. Vitamin D supplementation for preventing infections in children under five years of age. Cochrane Database Syst. Rev. 2016. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bergman, P.; Lindh, Å.U.; Björkhem-Bergman, L.; Lindh, J.D. Vitamin D and respiratory tract infections: A systematic review and meta-analysis of randomized controlled trials. PLoS ONE 2013, 8, e65835. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Simon, A.K.; Hollander, G.A.; McMichael, A. Evolution of the immune system in humans from infancy to old age. Proc. Biol. Sci. 2015, 282, 20143085. [Google Scholar] [CrossRef] [PubMed]
- Hill, T.R.; Aspray, T.J.; Francis, R.M. Vitamin D and bone health outcomes in older age. Proc. Nutr. Soc. 2013, 72, 372–380. [Google Scholar] [CrossRef]
- Holick, M.F.; Binkley, N.C.; Bischoff-Ferrari, H.A.; Gordon, C.M.; Hanley, D.A.; Heaney, R.P.; Murad, M.H.; Weaver, C.M.; Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 2011, 96, 1911–1930. [Google Scholar] [CrossRef] [Green Version]
- Sulaiman, Z.; Noor, N.M.; Ismail, S.B.; Mohd Lukman, A.S.F.; Irfan, M.; Hussain, N.H.N. Maternal Vitamin D Supplementation for the Prevention of Respiratory Tract Infections in Offspring: A Meta-Analysis. Korean J. Fam. Med. 2022, 43, 174–182. [Google Scholar] [CrossRef]
- Brustad, N.; Kim, M.; Skov, F.; Schoos, A.M.; Stokholm, J.; Bønnelykke, K.; Chawes, B.L. 25-hydroxyvitamin D and risk of atopic diseases and infections in early childhood. Allergy 2023. early view. [Google Scholar] [CrossRef]
- Asif, A.; Farooq, N. Vitamin D Toxicity. In StatPearls; StatPearls Publishing: Treasure Island, FL, USA, 2023. Available online: https://www.ncbi.nlm.nih.gov/books/NBK557876/ (accessed on 7 May 2023).
Study and Author | Country | Study Year | Study Design | Study Quality |
---|---|---|---|---|
1 [31] Leis et al. | Canada | 2012 | Case–Control | Good |
2 [32] Jensen et al. | Canada | 2016 | Randomized Trial | Excellent |
3 [33] Aglipay et al. | Canada | 2017 | Randomized Trial | Excellent |
4 [34] Hueniken et al. | Canada | 2019 | Randomized Trial | Good |
5 [35] Singh et al. | India | 2019 | Randomized Trial | Good |
6 [36] Ducharne et al. | Canada | 2019 | Randomized Trial | Excellent |
7 [37] Jadhav et al. | India | 2021 | Prospective Cohort | Fair |
8 [38] Xiao et al. | China | 2021 | Case–Control | Fair |
Study Number | Patients (Cases vs. Controls) | Average Age (Years) (Cases vs. Controls) | Gender (Female) (Cases vs. Controls) | Vitamin D Intake (IU) | Duration of Vitamin D Supplementation |
---|---|---|---|---|---|
1 [31] Leis et al. | 197 (105 vs. 92) | NR | 40.8% vs. 42.2% | 48/kg/day vs. 60/kg/day | 6 months |
2 [32] Jensen et al. | 22 (11 vs. 11) | 2.2 vs. 3.1 | 65.6% vs. 72.7% | 1 oral bolus of 50,000 + 400/day | 6 months |
3 [33] Aglipay et al. | 703 (349 vs. 354) | 2.70 vs. 2.76 | 45.2% vs. 39.4% | 2000/day vs. 400/day | 10 months |
4 [34] Hueniken et al. | 703 (349 vs. 354) | 2.70 vs. 2.76 | 45.2% vs. 39.4% | 2000/day vs. 400/day | 4–8 months |
5 [35] Singh et al. | 100 (50 vs. 50) | NR | 44.0% vs. 40.0% | 1 oral bolus of 300,000 + 400/day | 12 months |
6 [36] Ducharne et al. | 47 (23 vs. 24) | 2.9 vs. 2.9 | 30.0% vs. 42.0% | 2 oral boluses of 100,000 (3.5 months apart) | 7 months |
7 [37] Jadhav et al. | 298 (155 vs. 143) | 3.1 vs. 3.2 | 36.2% | 1 oral bolus of 120,000 + 400/day vs. 400/day | 6 months |
8 [38] Xiao et al. | 119 (60 vs. 59) | 4.8 vs. 4.8 | 28.3% vs. 30.5% | 800/day vs. 400/day | 3 months |
Study | Vitamin D Insufficiency Threshold | Vitamin D Levels * (Cases vs. Controls) ng/dL | Vitamin D Insufficiency (%) | Incidence of Infections (Cases vs. Controls) | Type of Infection |
---|---|---|---|---|---|
1 [31] | <20 ng/mL | NR | NR | 53.3% | Acute LRT |
2 [32] | <30 ng/mL | 36.0 vs. 32.0 | 75.0% | 70.8% vs. 76.0 | Viral URT |
3 [33] | <30 ng/mL | 48.7 vs. 36.8 | 5.7% vs. 22.2% | 52.7% vs. 54.5% | Acute URT |
4 [34] | <30 ng/mL | 48.7 vs. 36.8 | NR | 52.7% vs. 54.5% | Acute URT |
5 [35] | <20 ng/mL | 22.9 vs. 19.8 | 32.6% vs. 55.5% | 60.9% vs. 75.5% | Recurrent pneumonia |
6 [36] | <30 ng/mL | 32.8 vs. 30.5 | 68.0% vs. 54.0% | 87.2% | Acute URT |
7 [37] | NR | NR | NR | 68.8% | Recurrent LRT and URT |
8 [38] | <20 ng/mL | 20 vs. 16 | NR | NR | Recurrent LRT and URT |
Study Number | Severity of Infection (Cases vs. Controls) | Risk Assessment HR/OR/RR * (95% CI) | Other Study Particularities (Cases vs. Controls) |
---|---|---|---|
1 [31] Leis et al. | NR | OR = 4.90 (p = 0.010) <80 IU/kg/day (CI: 1.5–16.4) | Vitamin D intake < 80 IU/kg/day was statistically significantly associated with pneumonia (OR 7.9) but not bronchiolitis. |
2 [32] Jensen et al. | 64.0% vs. 73.0% acute care visits | RR = 0.74 (p > 0.050) (CI: 0.46–1.17) | There was a statistically significant change in the mean total 25OHD over the 6-month period, but no statistically significant difference in the URT infections per patient month of follow-up. |
3 [33] Aglipay et al. | 4.4% vs. 8.5% influenza | OR = 1.05 (p > 0.050) (CI: 0.91–1.19) | No statistically significant difference in the median time to the first infection (3.29 vs. 3.95 months). |
4 [34] Hueniken et al. | 6.6% vs. 6.5% ED visits | RR = 0.97 (p > 0.050) (CI: 0.76–1.23) | There was a statistically significant change in the mean total 25OHD at study termination, but no statistically significant decrease in symptoms per winter season, total outpatient visits, total ED visits, or total antibiotics prescribed |
5 [35] Singh et al. | 19.6% vs. 22.2% severe | RR = 0.69 (p > 0.050) (CI: NR) | Standard therapy with 300,000 IU of vitamin D in under-6 children with pneumonia decreased the URT and LRT infection severity, but it was not statistically significant. |
6 [36] Ducharne et al. | 61 vs. 44 asthma exacerbations | RR = 0.92 (p > 0.050) (CI: 0.58–1.49) | There was no statistically significant change in the mean total 25OHD at 3.5 and 7 months. Hypercalciuria was observed in 8.7% vs. 10.3%. |
7 [37] Jadhav et al. | 7.7% vs. 32.4% (3–4 episodes) after 1 oral bolus of 120,000 + 400/day | OR = 6.97 (p < 0.001) <80 IU/kg/day (CI: 3.5–13.8) | Children who received vitamin D supplementation recovered from ARTIs more quickly and had fewer episodes. |
8 [38] Xiao et al. | NR | RR = 0.55 (p < 0.001) (CI: NR) | Statistically significant reduction in URT and LRT infections after treatment. |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Marusca, L.M.; Reddy, G.; Blaj, M.; Prathipati, R.; Rosca, O.; Bratosin, F.; Bogdan, I.; Horhat, R.M.; Tapos, G.-F.; Marti, D.-T.; et al. The Effects of Vitamin D Supplementation on Respiratory Infections in Children under 6 Years Old: A Systematic Review. Diseases 2023, 11, 104. https://doi.org/10.3390/diseases11030104
Marusca LM, Reddy G, Blaj M, Prathipati R, Rosca O, Bratosin F, Bogdan I, Horhat RM, Tapos G-F, Marti D-T, et al. The Effects of Vitamin D Supplementation on Respiratory Infections in Children under 6 Years Old: A Systematic Review. Diseases. 2023; 11(3):104. https://doi.org/10.3390/diseases11030104
Chicago/Turabian StyleMarusca, Larisa Mihaela, Gowry Reddy, Mihaela Blaj, Reshmanth Prathipati, Ovidiu Rosca, Felix Bratosin, Iulia Bogdan, Razvan Mihai Horhat, Gabriela-Florentina Tapos, Daniela-Teodora Marti, and et al. 2023. "The Effects of Vitamin D Supplementation on Respiratory Infections in Children under 6 Years Old: A Systematic Review" Diseases 11, no. 3: 104. https://doi.org/10.3390/diseases11030104
APA StyleMarusca, L. M., Reddy, G., Blaj, M., Prathipati, R., Rosca, O., Bratosin, F., Bogdan, I., Horhat, R. M., Tapos, G. -F., Marti, D. -T., Susan, M., Pingilati, R. A., Horhat, F. G., & Adelina, M. (2023). The Effects of Vitamin D Supplementation on Respiratory Infections in Children under 6 Years Old: A Systematic Review. Diseases, 11(3), 104. https://doi.org/10.3390/diseases11030104